Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Bio-Rad Laboratories, Inc.
Type
Public (NYSE: BIO)
Industry Life science
Clinical Diagnostics
Founded 1952
Founder David and Alice Schwartz
Headquarters Hercules, California, U.S.A.
Area served
Worldwide
Key people

Norman Schwartz (Chairman),(President and CEO)
John Goetz (Chief Operating Officer)

Giovanni Magni (Chief Strategy Officer)
Christine Tsingos (Executive Vice President, CFO)
Shawn M. Soderberg (Executive Vice President, General Counsel and Secretary)
Shannon Hall (Executive Vice President, President Life Sciences Group)
John Hertia (Executive Vice President, President Clinical Diagnostics Group)
Ronald Hutton (Vice President, Treasurer)
James Stark (Vice President, Corporate Controller)
Revenue IncreaseUS$2.1 billion (FY 2013)
Operating income
IncreaseUS$295 million (FY 2011)
Net income
DecreaseUS$178 million (FY 2011)
Total assets IncreaseUS$3.097 billion (FY 2011)
Total equity IncreaseUS$1.744 billion (FY 2010)
Number of employees
7,030 (Dec 2011)
Divisions Life Science Research,
Clinical Diagnostics,
Website www.bio-rad.com

Bio-Rad Laboratories, Inc. was founded in 1952 in Berkeley, California. The company was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. Today, Bio-Rad manufactures and supplies life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate complex chemical and biological materials and to identify, analyze, and purify their components.

Investment goal date:
Dividends reinvested
Bio-Rad Laboratories, Inc. BIO report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-26
--
--
Q3 2017
2017-11-02
--
--
Q2 2017
2017-08-03
0.1700
0.1700
Q1 2017
2017-05-04
0.4200
0.4100
Q4 2016
2017-02-23
-0.7000
-0.7000
Q3 2016
2016-11-01
0.6200
0.6200
Q2 2016
2016-08-03
0.6100
0.6100
Q1 2016
2016-05-05
0.4200
0.4200
Q4 2015
2016-02-25
1.6800
1.6800
Q3 2015
2015-11-03
0.5900
0.5900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ACADIAN ASSET MANAGEMENT LLC
895241
ALLIANCEBERNSTEIN L.P.
335197
ARIEL INVESTMENTS, LLC
674360
BANK OF AMERICA CORP /DE/
365909
BlackRock Fund Advisors
873392
BlackRock Inc.
1733111
BlackRock Institutional Trust Company, N.A.
636888
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
432976
NWQ INVESTMENT MANAGEMENT COMPANY, LLC
324280
ROYAL BANK OF CANADA
328460
RUSSELL FRANK CO/
414391
STATE STREET CORP
536367
TimesSquare Capital Management, LLC
611700
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC
436833
Vanguard Group, Inc
1673274
Major Shareholders
Name Relationship
Total Shares
Holding stocks
SCHWARTZ STEVEN D
0.1000% (24892)
BIO /
SCHWARTZ NORMAN D
1.0200% (242865)
BIO /
GOETZ JOHN
0.2800% (66473)
BIO /
CRUTCHFIELD BRADFORD
0.0200% (5332)
BIO / NSTG /
HUTTON RONALD W
0.0100% (3449)
BIO /
WADLER SANFORD
0.0500% (12317)
BIO /
TSINGOS CHRISTINE A
0.0300% (6683)
BIO / NANO /
Magni Giovanni
0.0500% (11651)
BIO /
HERTIA JOHN
0.0500% (12562)
BIO /
% ()